Signal from the log
Anaconda Biomed
56 M$ · Undisclosed · Spain · Medtech
Anaconda Biomed fabrique un cathéter à entonnoir qui retire le caillot bouchant une artère du cerveau pendant un AVC. L'entonnoir se déploie dans le vaisseau pour arrêter le flux sanguin et l'inverser, de façon à éviter que le caillot se fragmente pendant l'aspiration. L'essai pivot ATHENA doit recruter 327 patients.
Verified
Announced on , logged by the watch of 23 September 2026.
- Operation
- Funding round
- Announced amount
- 56 M$
- Stage
- Undisclosed
- Country
- Spain
- Sector
- Medtech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Omega Funds , with COFIDES , Asabys Partners , Ysios Capital , CDTI Innvierte
Provenance
Logged on 23 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.